Current and emerging therapies for the treatment of myasthenia gravis

Myasthenia gravis (MG) is an autoimmmune disease in which autoantibodies to different antigens of the neuromuscular junction cause the typical weakness and fatigability. Treatment includes anticholinesterase drugs, immunosuppression, immunomodulation, and thymectomy. The autoimmune response is maint...

Descripción completa

Detalles Bibliográficos
Autores principales: Mantegazza, Renato, Bonanno, Silvia, Camera, Giorgia, Antozzi, Carlo
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3083988/
https://www.ncbi.nlm.nih.gov/pubmed/21552317
http://dx.doi.org/10.2147/NDT.S8915

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3083988/
https://www.ncbi.nlm.nih.gov/pubmed/21552317
http://dx.doi.org/10.2147/NDT.S8915

Ejemplares similares